or the use of epigenetic factors to modulate secondary metabolite regulation 3 . However, it is often difficult to predict which conditions, if any, will lead to expression of a particular cryptic gene cluster. Overexpression of pathway-specific regulators can be useful, but this is applicable only in genetically tractable hosts.
A more recent approach is the heterologous expression of cryptic clusters in a well-characterized host using sophisticated products are unknown or have not yet been detected. Most approaches for investigating cryptic gene clusters rely on eliciting their expression in the native host. For example, the 'one strain, many compounds' method 2 entails the manipulation of culture parameters, such as medium composition and aeration, to identify conditions that favor expression of secondary metabolite clusters. Other strategies involve co-culture of the organism of interest with additional species Methods for recovering genomic sequences of interest are among the most important tools in biotechnology, but many require laborious library generation and screening or several preparatory DNA amplification and assembly steps. In this issue, Fu et al. 1 introduce a cloning technique that allows for the direct transfer of large regions of genomic DNA into an Escherichia coli expression vector. They applied the approach to clone ten regions 10-52 kb in length from the genome of Photorhabdus luminescens and used the resulting constructs to rapidly identify two secondary meta bolites. Many potential applications of the method can be envisioned, including rapid hetero logous expression of known biosynthetic gene clusters in tractable hosts, bioprospecting for secondary metabolites, de novo gene cluster assembly and construction of cDNA libraries.
The ever-increasing numbers of sequenced genomes and metagenomes represent a rich source of secondary metabolite pathways for producing novel antibiotics and chemotherapeutics. But cloning these gene clusters is not trivial because most of them are quite large. Conventional cloning techniques are laborious and timeconsuming as they involve the construction and screening of genomic DNA libraries to identify pathways of interest. In addition, many genomes contain 'cryptic' gene clusters that encode pathways whose final Direct cloning of large genomic sequences
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The discovery of an efficient mechanism of homologous recombination between two linear DNA substrates provides a new method for direct cloning. DNA manipulation techniques. For example, the Gibson assembly method 4 enables onestep, isothermal assembly of large DNA molecules from several smaller fragments, which can be prepared via standard PCR or direct synthesis. Similar in vitro assembly protocols include sequence-and ligationindependent cloning 5 and circular polymerase extension cloning 6 . The Golden Gate assembly method 7 deploys unique type II restriction enzymes to facilitate assembly in vitro, whereas the DNA assembler method 8 uses the natural homologous recombination proficiency of Saccharomyces cerevisiae to assemble DNA fragments in vivo. Although these approaches bypass the need for conventional library generation and screening to isolate a gene cluster of interest, they never theless require multiple PCR amplification steps that could introduce random mutations. Mutations, insertions or deletions can also be introduced through incorrect pairing of fragments during the assembly process itself.
The cloning method presented by Fu et al. 1 rests on their discovery that there is a functional distinction between homologous recombination mechanisms that involve one linear and one circular DNA molecule and those that involve two linear DNA molecules. In a 'recombineering' experiment, an exonuclease and a single-strand annealing proteintypically the lambda phage proteins Redα and Redβ, respectively-are used to facilitate recombination between a circular DNA molecule (the bacterial chromosome) and a linear DNA fragment. Other proteins, such as the Rac phage proteins RecE and RecT, can also serve in this capacity, albeit with lower recombination efficiency. Notably, in contrast to the 226-amino-acid Redα protein, RecE is much larger, at 866 amino acids, of which only the last 260 amino acids constitute the exonuclease domain.
In their new study, Fu et al. 1 show for the first time that the full-length RecE protein can facilitate efficient recombination between two linear DNA substrates. Both the truncated RecE-RecT pair (in which only the exonuclease domain of RecE is expressed) and the Redα-Redβ pair are superior at standard recombineering compared with full-length RecE and RecT, but the latter catalyze homologous recombination between two linear DNA molecules with more than 20-fold greater efficiency.
This finding has immediate implications for the cloning of linear DNA constructs into linear vectors. The authors demonstrated the capabilities of their method by direct cloning of sequences from bacterial artificial chromosomes, cDNA and genomic DNA.
To illustrate the application of direct cloning to genome mining-the discovery of novel secondary metabolites solely from genomic sequence data-they chose the Gram-negative bacterium P. luminescens. Bioinformatics analysis of the sequenced genome identified a total of ten megasynthetase clusters, which are of significant biotechnological interest because of their potential to produce a variety of useful compounds such as antibiotics, chemotherapeutics, immunosuppressants and insecticides. For each of the ten clusters, Fu et al. 1 used restriction enzymes to cleave the genomic DNA upstream and downstream of the cluster, and then amplified a standard expression vector with a unique pair of oligonucleotides to introduce ends homologous to the boundaries of the cluster. Transformation of the linearized vector and digested genomic DNA into E. coli expressing full-length RecE-RecT enabled direct cloning of nine of the ten clusters, although two were found to be consistently mutated at their 5′ ends. Of the remaining seven, two produced detectable levels (>0.1 µg ml -1 ) of compounds, which were purified and identified as the secondary metabolites luminmycin A and luminmide A/B.
Cloning the tenth and largest (52-kb) locus required a two-step procedure. After full-length RecE-RecT cloning, most of the incorrect plasmids were recircularized empty vectors. To overcome this background, the authors added a second recombineering step in which a second antibiotic selection marker was introduced on a linear DNA fragment with homology arms corresponding to part of the target sequence. To facilitate recombination between this linear fragment and the correctly cloned circular plasmid, they expressed the Redα-Redβ recombineering proteins and selected clones in the presence of the second antibiotic. This amended protocol allowed successful cloning of the largest target gene.
Direct cloning as shown by Fu et al. 1 offers many advantages over other cloning and assembly methods (Fig. 1) . Compared with conventional random cloning methods, it circumvents the intermediate steps of library generation and screening to identify the target cluster. Compared with direct assembly methods, it does not require PCR amplification from genomic DNA and so minimizes the chances of introducing mutations. In addition, the use of a standard expression vector with a tetracycline-inducible promoter prevents constitutive expression of potentially toxic meta bolites, and a new pair of primers is all that is needed to target any new cluster.
Finally, both cloning and expression are carried out in E. coli, a well-studied and highly tractable host.
The approach also has several limitations. First, it requires the identification of unique restriction enzyme sites upstream and downstream of the target gene cluster. In particular, the 5′ site must be close to the start of the first gene to achieve the highest recombination efficiency. Second, efficiency is limited by the size of the target cluster, as seen with the 52-kb locus. Even with an additional selection step, the authors observed a recombination efficiency of only 29% (6 correct clones out of 21), which suggests that substantially larger contiguous DNA regions might not be accessible by this method. Third, preservation of the genetic context of the gene cluster could be detrimental to heterologous expression for various reasons, such as the presence of repressors or the absence of necessary activators. Fourth, if the gene cluster is not completely operonic in structure, the hetero logous host might not recognize the promoters of the native host, or it might express the genes at unbalanced levels. For gene clusters from eukaryotes, introns might not be processed correctly. Finally, direct cloning is not readily amenable to modification of the target gene cluster and thus requires supplemental techniques for further engineering.
As direct cloning is optimized in future studies, it would be of interest to determine whether the method can be extended to multiple genomic fragments, such as additional promoters or genes not found in the target gene cluster, or even to libraries of pathway variants. It would also be interesting to investigate whether similar recombination systems can be applied in hosts other than E. coli. Regardless of subsequent improvements, direct cloning is clearly a valuable new method that is well suited to mining the vast amount of genome and metagenome sequence data for applications in secondary metabolite discovery and synthetic biology.
